ADUS 241220 150.00C (ADUS241220C150000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

ADUS241220C150000

Watchlist

0.00
0.000.00%

15min DelayClose Dec 20 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst
BenzingaDec 16 13:52 ET
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
BenzingaDec 16 08:17 ET
Addus HomeCare Initiated at Market Outperform by JMP Securities
Dow JonesDec 16 05:58 ET · Ratings
JMP Securities Initiates Addus HomeCare(ADUS.US) With Buy Rating, Announces Target Price $150
Moomoo NewsDec 16 00:32 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Addus Homecare (ADUS)
TipRanksDec 16 00:30 ET · Ratings
Is It Too Late To Consider Buying Addus HomeCare Corporation (NASDAQ:ADUS)?
Simply Wall StDec 14 08:44 ET

Comments

Moomoo AI

Feb 25 06:40

Addus HomeCare's rising ROCE and capital employed are positive signs. The stock's past five-year performance suggests investors may be overlooking these promising trends, indicating potential investment opportunities.

Returns Are Gaining Momentum At Addus HomeCare (NASDAQ:ADUS)

Moomoo AI

Dec 30, 2023 07:49

The stock is undervalued, presenting a buying opportunity as future growth isn't fully reflected in the price. Consider the company's capital structure and management record before investing.

What Is Addus HomeCare Corporation's (NASDAQ:ADUS) Share Price Doing?

Moomoo AI

Dec 13, 2023 04:54

Insiders' lack of purchases last year may concern investors, but their ownership indicates alignment with investors. The largest recent insider sale matching the current share price could hint at limited growth. However, investment decisions shouldn't rely solely on directors' actions.

Addus HomeCare Insiders Sold US$3.5m Of Shares Suggesting Hesitancy

Moomoo AI

Nov 15, 2023 05:29

Addus HomeCare's rising ROCE and regular business investment make it a worthwhile consideration for investors. Its capacity to boost returns while expanding capital hints at future growth possibilities. Despite recent 27% return to shareholders, the company's growth potential may still be underestimated.

Addus HomeCare (NASDAQ:ADUS) Is Looking To Continue Growing Its Returns On Capital

Analysts Notebook

Apr 13, 2022 05:45

Columns Top upgrades and downgrades on 4/13

Upgrades
• $Booz Allen Hamilton Holding Corp (BAH.US)$: Goldman Sachs Upgrades to Buy from Neutral - PT $102 (from $83)
• $Humana (HUM.US)$: UBS Upgrades to Buy from Neutral - PT $520 (from $486)
• $JB Hunt Transport Services (JBHT.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $230 (from $210)
Downgrades
• $JB Hunt Transport Services (JBHT.US)$: B.Riley Downgrades to Neutral from Buy - PT $33 (from $62)
• $CACI International (CACI.US)$: Goldman Sachs Downgrad...